Published in Hum Genet on March 23, 2002
Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance. Cell (2010) 4.37
Congenital abnormalities of cranial nerve development: overview, molecular mechanisms, and further evidence of heterogeneity and complexity of syndromes with congenital limitation of eye movements. Trans Am Ophthalmol Soc (2004) 1.31
An inherited TUBB2B mutation alters a kinesin-binding site and causes polymicrogyria, CFEOM and axon dysinnervation. Hum Mol Genet (2012) 1.25
Three novel mutations in KIF21A highlight the importance of the third coiled-coil stalk domain in the etiology of CFEOM1. BMC Genet (2007) 1.19
Evidence of an asymmetrical endophenotype in congenital fibrosis of extraocular muscles type 3 resulting from TUBB3 mutations. Invest Ophthalmol Vis Sci (2010) 1.15
Human disorders of axon guidance. Curr Opin Neurobiol (2012) 1.01
The genetics of strabismus. J Med Genet (2004) 0.92
Congenital innervation dysgenesis syndrome (CID)/congenital cranial dysinnervation disorders (CCDDs). Eye (Lond) (2011) 0.86
Recurrent mutation of the KIF21A gene in Japanese patients with congenital fibrosis of the extraocular muscles. Jpn J Ophthalmol (2005) 0.85
KIF21A mutations in two Chinese families with congenital fibrosis of the extraocular muscles (CFEOM). Mol Vis (2010) 0.85
Lack of KIF21A mutations in congenital fibrosis of the extraocular muscles type I patients from consanguineous Saudi Arabian families. Mol Vis (2011) 0.84
Congenital fibrosis of the extraocular muscles type 1, distinctive conjunctival changes and intrapapillary disc colobomata. Ophthalmic Genet (2009) 0.76
KIF21A mutation in two Chinese families with congenital fibrosis of the extraocular muscles type 1 and 3. Mol Med Rep (2016) 0.75
Clinical presentation and management of congenital ptosis. Clin Ophthalmol (2017) 0.75
Congenital cranial dysinnervation disorders. Int Ophthalmol (2016) 0.75
Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance. Cell (2010) 4.37
Mutations in a human ROBO gene disrupt hindbrain axon pathway crossing and morphogenesis. Science (2004) 3.01
Comparison of macular and peripapillary measurements for the detection of glaucoma: an optical coherence tomography study. Ophthalmology (2005) 2.66
Duane radial ray syndrome (Okihiro syndrome) maps to 20q13 and results from mutations in SALL4, a new member of the SAL family. Am J Hum Genet (2002) 2.47
Structural grading of foveal hypoplasia using spectral-domain optical coherence tomography a predictor of visual acuity? Ophthalmology (2011) 2.42
Heterozygous mutations of the kinesin KIF21A in congenital fibrosis of the extraocular muscles type 1 (CFEOM1). Nat Genet (2003) 2.23
Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy. Am J Ophthalmol (2005) 2.21
Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders. Am J Med Genet B Neuropsychiatr Genet (2010) 2.12
Magnetic resonance imaging evidence for widespread orbital dysinnervation in congenital fibrosis of extraocular muscles due to mutations in KIF21A. Invest Ophthalmol Vis Sci (2005) 2.12
Homozygous HOXA1 mutations disrupt human brainstem, inner ear, cardiovascular and cognitive development. Nat Genet (2005) 1.98
Transient reduction in retinal function revealed by multifocal electroretinogram after photodynamic therapy. Am J Ophthalmol (2004) 1.91
Human CHN1 mutations hyperactivate alpha2-chimaerin and cause Duane's retraction syndrome. Science (2008) 1.84
Phenotypic spectrum of the tubulin-related disorders and functional implications of disease-causing mutations. Curr Opin Genet Dev (2011) 1.84
Recent progress in understanding congenital cranial dysinnervation disorders. J Neuroophthalmol (2011) 1.76
Magnetic resonance imaging evidence for widespread orbital dysinnervation in dominant Duane's retraction syndrome linked to the DURS2 locus. Invest Ophthalmol Vis Sci (2007) 1.75
Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. Am J Ophthalmol (2006) 1.69
Immunotherapy of ocular myasthenia gravis reduces conversion to generalized myasthenia gravis. J Neuroophthalmol (2003) 1.65
Alterations in upper airway cross-sectional area in response to lower body positive pressure in healthy subjects. Thorax (2007) 1.60
Noninvasive closure of a persistent cyclodialysis cleft. Ophthalmology (1996) 1.53
High-resolution magnetic resonance imaging demonstrates abnormalities of motor nerves and extraocular muscles in patients with neuropathic strabismus. J AAPOS (2006) 1.52
The preoperative assessment of the corneal endothelium. Aust N Z J Ophthalmol (1988) 1.52
Occurrence of malignant glaucoma after laser iridotomy. Br J Ophthalmol (1989) 1.49
Oral and intravenous steroids in giant cell arteritis. Clin Experiment Ophthalmol (2003) 1.44
Photodynamic therapy with or without intravitreal triamcinolone acetonide for symptomatic polypoidal choroidal vasculopathy. J Ocul Pharmacol Ther (2010) 1.43
Axonal loss and myelin in early ON loss in postacute optic neuritis. Ann Neurol (2008) 1.39
Hypoperfusion of the iris and its consequences in anterior segment pigment dispersal syndrome. Ophthalmic Surg (1994) 1.38
Intravitreal bevacizumab in inflammatory ocular neovascularization. Am J Ophthalmol (2008) 1.36
Impact of an exercise program on arterial stiffness and insulin resistance in hemodialysis patients. J Am Soc Nephrol (2004) 1.36
Identification of KIF21A mutations as a rare cause of congenital fibrosis of the extraocular muscles type 3 (CFEOM3). Invest Ophthalmol Vis Sci (2004) 1.36
Alignment artifacts in optical coherence tomography analyzed images. Ophthalmology (2006) 1.33
Regional variations in the relationship between macular thickness measurements and myopia. Invest Ophthalmol Vis Sci (2007) 1.33
Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis. Lancet Oncol (2006) 1.32
Visualization of anterior chamber angle dynamics using optical coherence tomography. Ophthalmology (2005) 1.28
An inherited TUBB2B mutation alters a kinesin-binding site and causes polymicrogyria, CFEOM and axon dysinnervation. Hum Mol Genet (2012) 1.25
The clinical applications of multifocal electroretinography: a systematic review. Surv Ophthalmol (2007) 1.20
Review of severe vaso-occlusive retinopathy in systemic lupus erythematosus and the antiphospholipid syndrome: associations, visual outcomes, complications and treatment. Clin Experiment Ophthalmol (2004) 1.19
The development of microneovascular changes in the iris in pseudoexfoliation of the lens capsule. Ophthalmology (1987) 1.19
Three novel mutations in KIF21A highlight the importance of the third coiled-coil stalk domain in the etiology of CFEOM1. BMC Genet (2007) 1.19
Genotype phenotype analysis of Bietti's crystalline dystrophy in patients with CYP4V2 mutations. Invest Ophthalmol Vis Sci (2007) 1.19
Intravitreal ranibizumab for the primary treatment of choroidal neovascularization secondary to pathologic myopia. Retina (2009) 1.18
Allelic diversity in human developmental neurogenetics: insights into biology and disease. Neuron (2010) 1.17
The clinical spectrum of homozygous HOXA1 mutations. Am J Med Genet A (2008) 1.16
A novel syndrome caused by the E410K amino acid substitution in the neuronal β-tubulin isotype 3. Brain (2013) 1.15
Magnetic resonance imaging of innervational and extraocular muscle abnormalities in Duane-radial ray syndrome. Invest Ophthalmol Vis Sci (2007) 1.15
Evidence of an asymmetrical endophenotype in congenital fibrosis of extraocular muscles type 3 resulting from TUBB3 mutations. Invest Ophthalmol Vis Sci (2010) 1.15
How to overcome barriers and establish a successful home HD program. Clin J Am Soc Nephrol (2012) 1.14
Congenital fibrosis of the extraocular muscles. Semin Ophthalmol (2008) 1.12
Reliable and valid NEWS for Chinese seniors: measuring perceived neighborhood attributes related to walking. Int J Behav Nutr Phys Act (2010) 1.12
Acute ataxia in childhood. J Child Neurol (2003) 1.12
Distinct alpha- and beta-tubulin isotypes are required for the positioning, differentiation and survival of neurons: new support for the 'multi-tubulin' hypothesis. Biosci Rep (2010) 1.11
Electrophysiological evidence for heterogeneity of lesions in optic neuritis. Invest Ophthalmol Vis Sci (2007) 1.10
Visual field and multifocal electroretinography and their correlations in patients on hydroxychloroquine therapy. Doc Ophthalmol (2006) 1.09
Abnormalities of the oculomotor nerve in congenital fibrosis of the extraocular muscles and congenital oculomotor palsy. Invest Ophthalmol Vis Sci (2007) 1.09
A novel KIF21A mutation in a patient with congenital fibrosis of the extraocular muscles and Marcus Gunn jaw-winking phenomenon. Arch Ophthalmol (2005) 1.08
Optic neuropathy secondary to radiotherapy for nasal melanoma. Clin Experiment Ophthalmol (2004) 1.08
Analysis of retinal nerve fiber layer and optic nerve head in glaucoma with different reference plane offsets, using optical coherence tomography. Invest Ophthalmol Vis Sci (2005) 1.08
Tolerance of the eye for implanted cilia. Br J Ophthalmol (1991) 1.04
Management of lens-iris diaphragm retropulsion syndrome. J Cataract Refract Surg (2005) 1.03
Intravitreal triamcinolone for diabetic macular oedema in Chinese patients: six-month prospective longitudinal pilot study. Clin Experiment Ophthalmol (2004) 1.03
Recurrent posterior capsular opacification and capsulorhexis contracture after cataract surgery in myotonic dystrophy. Clin Experiment Ophthalmol (2004) 1.02
Neurological features of congenital fibrosis of the extraocular muscles type 2 with mutations in PHOX2A. Brain (2006) 1.02
Fluorescein angiography and fluorophotometry of the iris in pseudoexfoliation of the lens capsule. Br J Ophthalmol (1983) 1.02
Human disorders of axon guidance. Curr Opin Neurobiol (2012) 1.01
Fresh frozen plasma for progressive and refractory angiotensin-converting enzyme inhibitor-induced angioedema. J Emerg Med (2012) 1.01
CHN1 mutations are not a common cause of sporadic Duane's retraction syndrome. Am J Med Genet A (2010) 1.00
Horner syndrome. Clin Exp Optom (2007) 1.00
Identifying anterior segment crystals. Br J Ophthalmol (1991) 1.00
Long-term visual outcomes of intravitreal bevacizumab in inflammatory ocular neovascularization. Am J Ophthalmol (2009) 1.00
Expansion of the CHN1 strabismus phenotype. Invest Ophthalmol Vis Sci (2011) 1.00
Comparison of specular microscopy and examination of aspirate in phacolytic glaucoma. Ophthalmology (1990) 0.99
Bilateral exudative retinal detachments as the presenting features of idiopathic orbital inflammation. Clin Experiment Ophthalmol (2005) 0.97
The therapeutic profile of rolipram, PDE target and mechanism of action as a neuroprotectant following spinal cord injury. PLoS One (2012) 0.97
Three-year visual and anatomic results of administrating intravitreal bevacizumab in inflammatory ocular neovascularization. Can J Ophthalmol (2012) 0.96
HOXB1 founder mutation in humans recapitulates the phenotype of Hoxb1-/- mice. Am J Hum Genet (2012) 0.96
Delineating the position of rad4+/cut5+ within the DNA-structure checkpoint pathways in Schizosaccharomyces pombe. J Cell Sci (2003) 0.95
The risks of precipitating acute angle-closure glaucoma with the clinical use of mydriatic agents. Med J Aust (1986) 0.95
Magnetic resonance imaging of the endophenotype of a novel familial Möbius-like syndrome. J AAPOS (2008) 0.94
HOXA1 mutations are not a common cause of Duane anomaly. Am J Med Genet A (2006) 0.94
Pregnancy in end stage renal disease. Semin Dial (2011) 0.94
Argon laser trabeculoplasty five years on. Aust N Z J Ophthalmol (1988) 0.94
A novel PHOX2A/ARIX mutation in an Iranian family with congenital fibrosis of extraocular muscles type 2 (CFEOM2). Am J Ophthalmol (2003) 0.93
Crystalline nature of the iridescent particles in hypermature cataracts. Br J Ophthalmol (1994) 0.92
Impact of renal insufficiency on outcome after contemporary percutaneous coronary intervention. Am Heart J (2006) 0.92
Simple technique for recession of the inferior oblique muscle. Br J Ophthalmol (1970) 0.92
Photodynamic therapy in the management of juxtapapillary capillary haemangiomas. Clin Experiment Ophthalmol (2005) 0.91